Human Genes

The Curious Case Of Human Gene Patents

by Thomas Engellenner | Pepper Hamilton LLP on 5/22/2013

The U.S. Supreme Court heard oral arguments last month in the matter of Association for Molecular Pathology v. Myriad Genetics, a curious case that does not bode well for America’s biotechnology industry and could overturn 30...more

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 5/15/2013

The biggest concern of the biotechnology industry caused by the impending Supreme Court decision in the AMP v. Myriad Genetics case is the threat to existing patents having claims to isolated human DNA (and the DNA from other...more

Rubin v. General Hospital Corp. (Fed. Cir. 2013)

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 5/8/2013

On March 28, the Federal Circuit in Rubin v. General Hospital Corp. affirmed judgment by the District Court for the District of Massachusetts dismissing the suit brought by Drs. Berish Rubin and Sylvia Anderson against The...more

A Perspective on the Cost of the Myriad BRCA Gene Test

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 5/3/2013

One of the most compelling arguments in the gene patenting debate with the public has been the cost of the Myriad BRCA gene test: $3,000 per test, a price that many without insurance coverage cannot afford. The argument...more

Bernstein Shur Business and Commercial Litigation Newsletter #27

by Paul McDonald, Daniel J. Murphy | Bernstein Shur on 5/2/2013

We are pleased to present the 27th edition of the Bernstein Shur Business and Commercial Litigation Newsletter. This month, we highlight stories that will have an impact on business, commerce and litigation, including the...more

IP Buzz - April 2013

by Therese Finan, Meaghan Hemmings Kent, Jeffrey D. Knowles, Martin Saad, Steven Schwarz | Venable LLP on 5/1/2013

In this issue: - Federal Circuit: Speak Now or Forever Hold Your Appeal - The Federal Circuit Draws the Line on Permissible Changes to Design Patent Claims – Or Does It? - DMCA Safe Harbor Upheld for...more

Dispelling the Myriad Gene Patent Harmonization Myth

by Courtenay C. Brinckerhoff | Foley & Lardner LLP on 5/1/2013

In the wake of the Supreme Court oral arguments in the Myriad “gene patent” case, most commentators are predicting that the Court will uphold the patent-eligibility of non-naturally occurring DNA sequences (such as cDNA), but...more

Supreme Debate: Are Human Genes Patentable?

by Therese Finan | Venable LLP on 5/1/2013

On April 15, 2013, tackling an issue of significant importance to the biotechnology and health care industries, the U.S. Supreme Court heard oral arguments over whether human genes are patentable and more specifically,...more

[Legal Perspective] Can Human Genes Be Patented?

by JD Supra Law News on 4/24/2013

Earlier this month, the United States Supreme Court heard oral arguments in a case that comes down to a single question: can human genes be patented?...more

Are Human Genes Patentable? Supreme Court Hears Oral Arguments in Myriad Case [Video]

by LXBN on 4/23/2013

The necessary balance between incentivizing and rewarding innovation with making those innovations widely available—and not stifling advancements by keeping competitors down—has been at the heart of patent law for some time....more

Batting Practice with DNA Patents at the U.S. Supreme Court

by Heather Khassian, Karthika Perumal, Ph.D., Michael R. Samardzija, Ph.D. | Bracewell & Giuliani LLP on 4/17/2013

The Supreme Court heard oral arguments today in Association of Molecular Pathology vs. Myriad Genetics (Docket 12-398) regarding the patent eligibility of isolated DNA sequences. More specifically, they probed both parties in...more

After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

by Marc Hearron, Matthew Kreeger, James J. Mullen, III | Morrison & Foerster LLP on 4/16/2013

Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to decide the question, “Are human genes patentable?” The Court’s decision in...more

Myriad Genetic Database Under Siege

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 4/15/2013

With the U.S. Supreme Court set to consider the patent-eligibility of claims to isolated human DNA in AMP v. Myriad Genetics this morning, another aspect of Myriad’s control over BRCA testing technology is being contested. ...more

"Human Genes" and Patents

by Antoinette F. Konski | Foley & Lardner LLP on 4/15/2013

At 10:00 A.M. on April 15th, the U.S. Supreme Court will entertain oral arguments in the dispute now known as the human “gene patenting” case. The Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398...more

A Primer on Claim Construction -- Comments on Dr. Mason's Response

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 4/12/2013

Yesterday, we posted a response from Dr. Chris Mason of Cornell University to a recent Patent Docs post and an article posted by Dr. Chris Holman on Holman's Biotech IP Blog. Dr. Mason co-authored an article in the current...more

A Response to Dr. Mason's "Rebuttal" to Criticisms of His Genomics Medicine Article

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 4/12/2013

Much of the gene patenting debate has appeared, to experienced patent practitioners, to be akin to a conversation with Kevin Kline's character in A Fish Called Wanda, or perhaps a passage from P.G. Wodehouse's The Luck of the...more

Can You Patent Human Genes? ACLU Says No [Video]

by Bloomberg Law on 4/12/2013

April 12 (Bloomberg Law) -- On April 15, 2013, the United States Supreme Court will hear oral arguments for Association for Molecular Pathology v. Myriad Genetics, Inc. The case centers on whether patents may be granted on...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

The Curious Case Of Human Gene Patents

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

Rubin v. General Hospital Corp. (Fed. Cir. 2013)

A Perspective on the Cost of the Myriad BRCA Gene Test

Bernstein Shur Business and Commercial Litigation Newsletter #27

IP Buzz - April 2013

Dispelling the Myriad Gene Patent Harmonization Myth

Supreme Debate: Are Human Genes Patentable?

[Legal Perspective] Can Human Genes Be Patented?

Are Human Genes Patentable? Supreme Court Hears Oral Arguments in Myriad Case [Video]

Batting Practice with DNA Patents at the U.S. Supreme Court

After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

Myriad Genetic Database Under Siege

"Human Genes" and Patents

A Primer on Claim Construction -- Comments on Dr. Mason's Response

A Response to Dr. Mason's "Rebuttal" to Criticisms of His Genomics Medicine Article

Can You Patent Human Genes? ACLU Says No [Video]

Dr. Chris Mason Responds to Blog Posts on Genome Medicine Article -- Updated

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes - [Video]

Genome Medicine Article Calls for Limits on Patenting of Existing Nucleotide Sequences

Supreme Court To Hear Oral Arguments in Landmark Patent Case

Is Lack of Preemption the Key for the Supreme Court to Decide in Myriad's Favor?

Intellectual Property LEGAL NEWS - March 22, 2013 • Volume 1, Number 2

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes [Video]

IPO Files Amicus Brief in Support of Respondents in AMP v. Myriad Genetics

Are Human Genes Patentable? Supreme Court Hears Oral Arguments in Myriad Case [Video]

Can You Patent Human Genes? ACLU Says No [Video]

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes - [Video]

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes [Video]

Expand Your Reach